Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,982 | $5,515 | $5,618 | $1,410 |
| % Growth | 44.7% | -1.8% | 298.4% | – |
| Cost of Goods Sold | $6,329 | $4,107 | $4,556 | $980 |
| Gross Profit | $1,653 | $1,409 | $1,062 | $430 |
| % Margin | 20.7% | 25.5% | 18.9% | 30.5% |
| R&D Expenses | $585 | $240 | $0 | $0 |
| G&A Expenses | $4,770 | $4,007 | $3,106 | $416 |
| SG&A Expenses | $1,445 | $4,007 | $3,106 | $416 |
| Sales & Mktg Exp. | -$3,325 | $0 | $0 | $0 |
| Other Operating Expenses | $3,388 | $52 | $46 | $18 |
| Operating Expenses | $5,418 | $4,299 | $3,151 | $434 |
| Operating Income | -$3,765 | -$2,888 | -$2,090 | -$3 |
| % Margin | -47.2% | -52.4% | -37.2% | -0.2% |
| Other Income/Exp. Net | $6 | -$51 | -$28 | $0 |
| Pre-Tax Income | -$3,759 | -$2,938 | -$2,118 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,759 | -$2,938 | -$2,118 | -$3 |
| % Margin | -47.1% | -53.3% | -37.7% | -0.2% |
| EPS | -0.52 | -0.6 | -0.36 | -0.001 |
| % Growth | 13.3% | -66.7% | -71,900% | – |
| EPS Diluted | -0.52 | -0.6 | -0.29 | -0.001 |
| Weighted Avg Shares Out | 7,265 | 4,878 | 5,860 | 7,283 |
| Weighted Avg Shares Out Dil | 7,265 | 4,878 | 7,283 | 7,283 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21 | $3 | $0 | $0 |
| Interest Expense | $16 | $54 | $29 | $0 |
| Depreciation & Amortization | $63 | $49 | $15 | $0 |
| EBITDA | -$3,681 | -$2,836 | -$2,075 | -$3 |
| % Margin | -46.1% | -51.4% | -36.9% | -0.2% |